Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

OTHER 5NIH 5NETWORK 3INDUSTRY 1

Study Type

Observational 3

Sponsor

Cancer Type

Dermatologic 3

Conditions

Leukemia 27Lymphoma 10Leukemia, Myeloid, Acute 9Sarcoma 8Kidney Neoplasms 7Congenital Abnormalities 7Breast Neoplasms 7Leukemia, Megakaryoblastic, Acute 6Leukemia, Myelomonocytic, Acute 5Leukemia, Monocytic, Acute 5Leukemia, Erythroblastic, Acute 5Carcinoma, Non-Small-Cell Lung 5Wilms Tumor 4Squamous Cell Carcinoma of Head and Neck 4Neuroblastoma 4Lymphoma, Follicular 4Lung Neoplasms 4Head and Neck Neoplasms 4Central Nervous System Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Melanoma 3Lymphoma, Large B-Cell, Diffuse 3Testicular Neoplasms 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Neoplasms 2Multiple Myeloma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2

Interventions

Interferon-alpha 6Radiosurgery 4Dacarbazine 4encorafenib 3binimetinib 3aldesleukin 3Immunohistochemistry 3Gene Expression Profiling 3Filgrastim 3Cisplatin 3Vinblastine 2Temozolomide 2Radiotherapy 2Polymerase Chain Reaction 2Nivolumab 2Ipilimumab 2Immunologic Techniques 2Flow Cytometry 2trametinib 1sulforaphane 1sargramostim 1romidepsin 1perifosine 1pembrolizumab 1peginterferon alfa-2b 1montanide ISA 51 1lorukafusp alfa 1incomplete Freund's adjuvant 1dipeptidase 1 1dabrafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Melanoma × Gene Expression Profiling × Clear all
NCT00898183 2018-06-28

S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma

SWOG Cancer Research Network

Completed
91 enrolled
Dermatologic

Melanoma

NCT00937781 2017-05-17

Study of Tumor Tissue From Patients With Melanoma Treated on Clinical Trial EST-1690

Eastern Cooperative Oncology Group

Completed
307 enrolled
Dermatologic

Melanoma

NCT01209299 2017-05-17

Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate

Eastern Cooperative Oncology Group

Completed
80 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡